JAK Inhibitor Tapering in Rheumatoid Arthritis: Implications for Patients in Sustained Remission - Rheumatology Advisor
JAK Inhibitor Tapering in Rheumatoid Arthritis: Implications for Patients in Sustained Remission Rheumatology Advisor
Data have demonstrated that patients with rheumatoid arthritis in long-term remission can safely taper their biologic therapy.
Comments
Post a Comment